Cell-signaling pathway plays key role in development of gestational diabetes

   Mar 17, 5:36 pm

Washington, March 17 (ANI): Scientists have identified a cell-signaling pathway that plays a key role in increasing insulin secretion during pregnancy and, when blocked, leads to the development of gestational diabetes.

During pregnancy, pancreatic beta cells should expand and produce more insulin to adapt to the needs of the growing baby, explained senior investigator Adolfo Garcia-Ocana, Ph.D., associate professor of medicine, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine.

Newborns can suffer complications if the mother's blood glucose is abnormally high during pregnancy, a condition known as gestational diabetes.

"Not much was known about the maternal mechanisms that lead to increased beta cell number and function during pregnancy," Dr. Garcia-Ocana said.

"But research has shown that high blood glucose in pregnancy can have long-term health consequences for the child, as well as a greater risk of hypertension, type 2 diabetes, and high cholesterol for the mother," he noted.

His team began studying a protein called hepatocyte growth factor (HGF), which was discovered by George K. Michalopoulos, M.D., Ph.D., professor and chair, Department of Pathology, Pitt School of Medicine, in 1990.

Blood levels of HGF are markedly increased in pregnancy. The protein interacts with a cell surface receptor called c-MET.

The researchers engineered mice that lacked the c-MET receptor in pancreatic cells and found that their beta cells functioned correctly, keeping blood glucose within normal parameters in adult mice. But when the mice got pregnant, they took on the features of gestational diabetes.

"Mice that didn't have the c-MET receptor in their pancreas had lower plasma insulin levels, higher blood glucose and impaired ability to regulate glucose levels. Without the receptor, they couldn't respond to HGF," Dr. Garcia-Ocana said.

Also, unlike normal healthy pregnant females, these mice didn't produce more beta cells, had more beta cell death and so had reduced beta cell mass.

"These findings provide the first direct evidence that HGF/C-MET signaling pathway has an important role in maternal beta cell adaptation during pregnancy," Dr. Garcia-Ocana noted.

"Perhaps women who have a variation in the HGF gene or in the c-MET receptor are predisposed to developing gestational diabetes because they cannot adequately compensate for the increased insulin demands of pregnancy," he stated.

In future work, he and his team will explore HGF signaling in pregnant women, which could one day provide a new means of diagnosing, treating or preventing gestational diabetes.

Their findings are available online today in Diabetes, one of the journals of the American Diabetes Association. (ANI)

Pulmonary hypertension's links with diabetes, cancer discovered Oct 31, 3:02 pm
Washington, Oct 31 (ANI): A team of scientists have discovered pulmonary hypertension's links with diabetes and cancer.
Full Story
Seizures, migraines produced by single gene mutation Oct 31, 2:14 pm
Washington, Oct 31 (ANI): In a new study, scientists have found that seizures and migraines may actually be linked as they could be produced by a single gene mutation.
Full Story
Today's kids could experience time travel, invisibility cloaks during lifetimes Oct 31, 1:35 pm
London, Oct 31 (ANI): A new study has predicted that some of the amazing phenomenons like time travel, invisibility cloaks and teleportation could be part of everyday life of today's kids by 2025.
Full Story
Newborn babies' weight governs risk for future diseases Oct 31, 1:35 pm
Washington, Oct 31 (ANI): A new study has shown a link between a baby's weight at the time of birth and the risk of diseases in the longer run.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY